Intermittent blood flow restriction with low-load resistance training for older adults with knee osteoarthritis: a randomized, controlled, non-inferiority trial protocol
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Intermittent blood flow restriction with low-load resistance training for older adults with knee osteoarthritis: a randomized, controlled, non-inferiority trial protocol ; volume:25 ; number:1 ; day:31 ; month:5 ; year:2024 ; pages:1-12 ; date:12.2024
Trials ; 25, Heft 1 (31.5.2024), 1-12, 12.2024
- Creator
-
Hong, Qiao-Mei
Wang, Hao-Nan
Liu, Xi-Hui
Zhou, Wen-Qi
Luo, Xiao-Bing
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13063-024-08203-9
- URN
-
urn:nbn:de:101:1-2408082119305.156160671812
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:01 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Hong, Qiao-Mei
- Wang, Hao-Nan
- Liu, Xi-Hui
- Zhou, Wen-Qi
- Luo, Xiao-Bing
- SpringerLink (Online service)
Other Objects (12)
Is there a danger of “biocreep” with non-inferiority trials?
Intermittent screening and treatment with artemether–lumefantrine versus intermittent preventive treatment with sulfadoxine–pyrimethamine for malaria in pregnancy: a facility-based, open-label, non-inferiority trial in Nigeria
Through the looking glass: understanding non-inferiority
Handling an uncertain control group event risk in non-inferiority trials: non-inferiority frontiers and the power-stabilising transformation
Robust designs in non-inferiority three arm clinical trials with presence of heteroscedasticity
Design choices for small-scale phase II trials with non-inferiority (NI) intention
Robust designs in non-inferiority three arm clinical trials with presence of heteroscedasticity
Non-efficacy benefits and non-inferiority margins: a scoping review of contemporary high-impact non-inferiority trials in clinical cardiology
Heliotherapy for neonates with severe-to-hazardous hyperbilirubinemia: a randomized controlled, non-inferiority trial
Bayes factors for superiority, non-inferiority, and equivalence designs
Understanding the null hypothesis (H0) in non-inferiority trials
Demonstrating equivalence and non-inferiority of medical education concepts
Is there a danger of “biocreep” with non-inferiority trials?
Intermittent screening and treatment with artemether–lumefantrine versus intermittent preventive treatment with sulfadoxine–pyrimethamine for malaria in pregnancy: a facility-based, open-label, non-inferiority trial in Nigeria
Through the looking glass: understanding non-inferiority
Handling an uncertain control group event risk in non-inferiority trials: non-inferiority frontiers and the power-stabilising transformation
Robust designs in non-inferiority three arm clinical trials with presence of heteroscedasticity
Design choices for small-scale phase II trials with non-inferiority (NI) intention
Robust designs in non-inferiority three arm clinical trials with presence of heteroscedasticity
Non-efficacy benefits and non-inferiority margins: a scoping review of contemporary high-impact non-inferiority trials in clinical cardiology
Heliotherapy for neonates with severe-to-hazardous hyperbilirubinemia: a randomized controlled, non-inferiority trial
Bayes factors for superiority, non-inferiority, and equivalence designs
Understanding the null hypothesis (H0) in non-inferiority trials
Demonstrating equivalence and non-inferiority of medical education concepts
Is there a danger of “biocreep” with non-inferiority trials?
Intermittent screening and treatment with artemether–lumefantrine versus intermittent preventive treatment with sulfadoxine–pyrimethamine for malaria in pregnancy: a facility-based, open-label, non-inferiority trial in Nigeria
Through the looking glass: understanding non-inferiority
Handling an uncertain control group event risk in non-inferiority trials: non-inferiority frontiers and the power-stabilising transformation
Robust designs in non-inferiority three arm clinical trials with presence of heteroscedasticity
Design choices for small-scale phase II trials with non-inferiority (NI) intention
Robust designs in non-inferiority three arm clinical trials with presence of heteroscedasticity
Non-efficacy benefits and non-inferiority margins: a scoping review of contemporary high-impact non-inferiority trials in clinical cardiology
Heliotherapy for neonates with severe-to-hazardous hyperbilirubinemia: a randomized controlled, non-inferiority trial
Bayes factors for superiority, non-inferiority, and equivalence designs
Understanding the null hypothesis (H0) in non-inferiority trials